|Abbott's Voyager NC balloon dilation catheter|
Abbott Vascular (Booth 2761) is introducing its Xience V everolimus-eluting coronary stent system and its Voyager NC balloon dilation catheter for the treatment of coronary artery disease (CAD). The Xience V, the latest DES to become FDA-approved, releases everolimus, which has been shown to help prevent restenosis.
The Voyager NC is Abbott's next-generation balloon dilatation catheter for the treatment of CAD. The device was designed to restore blood flow in both pre-dilatation and post-dilatation procedures, and is available in several balloon diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm). The Voyager NC is available on a rapid exchange delivery system.